What metrics would you use to evaluate Syneos Health's Patient Recruitment and Retention services?

Introduction

Evaluating Syneos Health's Patient Recruitment and Retention services requires a comprehensive approach to product success metrics. These services play a crucial role in clinical trials, directly impacting the efficiency and effectiveness of drug development. To address this complex challenge, I'll follow a structured framework covering core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

Syneos Health's Patient Recruitment and Retention services are designed to help pharmaceutical companies and clinical research organizations (CROs) find and keep suitable participants for clinical trials. This service encompasses patient identification, screening, enrollment, and ongoing engagement throughout the study duration.

Key stakeholders include:

1. Pharmaceutical companies: Seeking efficient trial completion
2. Clinical research organizations: Managing trial logistics
3. Healthcare providers: Referring potential participants
4. Patients: Seeking treatment options or compensation
5. Regulatory bodies: Ensuring ethical and compliant practices

User flow:

1. Patient identification: Syneos uses data analytics and targeted outreach to find potential participants.
2. Screening: Candidates undergo initial assessments to determine eligibility.
3. Enrollment: Qualified patients are onboarded into the trial.
4. Retention: Ongoing support and engagement to ensure participants complete the study.

This service is critical to Syneos Health's broader strategy of providing end-to-end solutions for clinical trials, differentiating them in the competitive CRO market. Compared to competitors like IQVIA or PPD, Syneos emphasizes its integrated approach and data-driven methodologies.

Product Lifecycle Stage: Mature, with ongoing innovation in data analytics and patient engagement technologies to maintain competitive edge.